Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy
In Vivo · 2026
DOI: 10.21873/invivo.14216 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2026. Verfasst von Ece Duygu Gulsen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Baskent University Faculty of Medicine, Ankara, Türkiye. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Neoadjuvant Therapy, Lung Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Baskent University Faculty of Medicine, Ankara, Türkiye.
- Department of Medical Oncology, Baskent University Faculty of Medicine, Ankara, Türkiye; rismayilov@baskent.edu.tr.
- Department of Medical Oncology, Baskent University Faculty of Medicine, Ankara, Türkiye.
- Department of Thoracic Surgery, Baskent University Faculty of Medicine, Ankara, Türkiye.
Zitieren
APA
Gulsen, E. D., Ismayilov, R., Farzaliyeva, A., Ramazanoglu, M. N., Oguz, A., Kilic, D., Akcali, Z., & Altundag, O. (2026). Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy. In Vivo. https://doi.org/10.21873/invivo.14216
Vancouver
Gulsen ED, Ismayilov R, Farzaliyeva A, Ramazanoglu MN, Oguz A, Kilic D, et al. Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy. In Vivo. 2026. doi:10.21873/invivo.14216
BibTeX
@article{Gulsen2026,
author = {Gulsen, Ece Duygu and Ismayilov, Rashad and Farzaliyeva, Aydan and Ramazanoglu, Mehmet Nezir and Oguz, Arzu and Kilic, Dalokay and Akcali, Zafer and Altundag, Ozden},
title = {Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy},
journal = {In Vivo},
year = {2026},
doi = {10.21873/invivo.14216}
}
EUVIMED